BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program
23 oct. 2019 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Oct. 23, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the...
BioRestorative Therapies Scientific Advisory Board Member and Clinical Director of Regenerative Disc/Spine Program, Dr. Wayne J. Olan, to Receive Prestigious Award
16 sept. 2019 08h00 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 16, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that a...
BioRestorative Therapies Comments on Recent Promotional Activity
13 sept. 2019 20h00 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 13, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell - based therapies, is providing comment on...
BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome
11 sept. 2019 08h00 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 11, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
BioRestorative Therapies’ Stockholders Approve Institutional Investor Agreement and Exchange Agreements
05 sept. 2019 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 05, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that, at...
BioRestorative Therapies Signs $5.4 Million Financing with Institutional Investor
31 juil. 2019 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., July 31, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
BioRestorative Therapies to Present at the 22nd Annual American Society of Gene and Cell Therapy as to Data on its Platform Technology for the Treatment of Metabolic Disorders
29 avr. 2019 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., April 29, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Announces the Creation of a Disc Advisory Committee
27 févr. 2019 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Feb. 27, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in the United States
15 nov. 2018 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Nov. 15, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Announces the Appointment of Lance Alstodt as Executive VP and Chief Strategy Officer
18 oct. 2018 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Oct. 18, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today...